檢測(cè)違禁品含抗體免疫檢測(cè)試劑盒

廣州健侖生物科技有限公司

廣州健侖生物科技有限公司是集研制開(kāi)發(fā)、銷(xiāo)售、服務(wù)于一體的優(yōu)良企業(yè),公司產(chǎn)品涉及臨床快速診斷試劑、食品安全檢測(cè)試劑，違禁品快速檢測(cè)，動(dòng)物疾病防疫檢測(cè)試劑，免疫診斷試劑、臨床血液學(xué)和體液學(xué)檢驗(yàn)試劑、微生物檢驗(yàn)試劑、分子生物學(xué)檢驗(yàn)試劑、臨床生化試劑、有機(jī)試劑等眾多領(lǐng)域，同時(shí)核心代理Panbio、FOCUS、Qiagen、IBL、CORTEZ、Fuller、Inbios、BinaxNOW、LumuQuick、日本富士、日本生研等多家有名診斷產(chǎn)品集團(tuán)公司產(chǎn)品，致力于為商檢單位、疾病預(yù)防控制中心、海關(guān)出入境檢疫局、衛(wèi)生防疫單位,緝毒系統(tǒng)，戒毒中心，檢驗(yàn)檢疫單位、生化企業(yè)、科研院所、醫(yī)療機(jī)構(gòu)等機(jī)構(gòu)與行業(yè)提供*、高品質(zhì)的產(chǎn)品服務(wù)。此外，本公司還開(kāi)展食品、衛(wèi)生、環(huán)境、藥品等多方面的第三方檢測(cè)服務(wù)。

廣州健侖生物長(zhǎng)期供應(yīng)各種違禁品檢測(cè)試紙、違禁品檢測(cè)卡、違禁品檢測(cè)試劑盒、藥篩試紙、藥篩試劑盒、嗎啡檢測(cè)試劑盒、巴比妥檢測(cè)試劑盒等。

使用說(shuō)明書(shū)

【產(chǎn)品名稱(chēng)】

通用名稱(chēng)：檢測(cè)違禁品含抗體免疫檢測(cè)試劑盒

英文名稱(chēng)：Diagnostic Kit for Nicotine（Colloidal Gold）

【包裝規(guī)格】 

1人份/袋、40人份/盒

Multi DOA Screen Panel are rapid chromatographic immunoassays for the qualitative and simultaneous detection of one to fourteen of the following drugs in a variety of combinations in human urine. The designed cutoff concentrations and direct calibrator for these drugs are as follows:

The test is used to obtain visual qualitative result and is intended for health care professionals use including professionals at point of care sites to assist in the determination of drug compliance. It is not intended for over the counter sale to non-professionals.

This assay provided only a preliminary analytical test result. A more specific alternative chemical method must be used in order to obtain a confirmed analytical result. Gas Chromatography/ Mass Spectrometry (GC/MS) or Liquid Chromatography/ Mass Spectrometry (LC/MS) are the preferred confirmatory method. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated.

本品采用競(jìng)爭(zhēng)抑制法和膠體金免疫層析技術(shù)，用于定性檢測(cè)人體尿液中尼古丁，適用于尼古丁藥物濫用的初步篩查。

主營(yíng)品牌：美國(guó)NovaBios、美國(guó)Cortez、國(guó)產(chǎn)創(chuàng)侖等等。

主要用途：篩查違禁品濫用殘留、麻醉藥殘留、興奮藥物殘留等等。

檢測(cè)范圍：嗎啡、KET、mamp、MDMA、BZO、THC、巴比妥、MTD、BAR、MDMA、AMP、BUP、PCP、TCA、OXY、MET等等。

產(chǎn)品特點(diǎn)：可以根據(jù)需求自主訂制多聯(lián)卡。多聯(lián)卡自由組合，從二聯(lián)到十五聯(lián)都可以訂制。

我司還提供其它進(jìn)口或國(guó)產(chǎn)試劑盒：登革熱、瘧疾、流感、A鏈球菌、合胞病毒、腮病毒、乙腦、寨卡、黃熱病、基孔肯雅熱、克錐蟲(chóng)病、違禁品濫用、肺炎球菌、軍團(tuán)菌、化妝品檢測(cè)、食品安全檢測(cè)等試劑盒以及日本生研細(xì)菌分型診斷血清、德國(guó)SiFin診斷血清、丹麥SSI診斷血清等產(chǎn)品。

如需訂購(gòu)或者了解請(qǐng)以下或

mob： 楊   ： 

美國(guó)NOVABIOS多聯(lián)檢測(cè)杯簡(jiǎn)介：

美國(guó)NOVABIOS單卡產(chǎn)品簡(jiǎn)介：

w the test device, urine specimen, and/or controls to reach room temperature (15-30oC) prior to t

更多產(chǎn)品說(shuō)明可通過(guò)下方的進(jìn)行了解

添加掃一掃二維碼：

【公司名稱(chēng)】 廣州健侖生物科技有限公司

【 市場(chǎng)部 】       楊永漢
【】 
【騰訊  】
【公司地址】 廣州市清華科技園健新基地番禺石樓鎮(zhèn)健啟路63號(hào)二期2幢101-103室

例如心  瓣膜病時(shí)的心 肌線(xiàn)粒體、周?chē)貉h(huán)障礙伴間歇性跛行時(shí)的骨  骼肌線(xiàn)粒體的 呈增生現(xiàn)象。線(xiàn)粒體數(shù)量減少則見(jiàn)于急性細(xì)胞損傷  時(shí)線(xiàn)粒體崩解 或自溶的情況下，持續(xù)約分鐘。慢性損傷時(shí)由于線(xiàn)  粒體逐漸增生 ，故一般不見(jiàn)線(xiàn)粒體減少（甚至反而增多）。此外  ，線(xiàn)粒體的減 少也是細(xì)胞未成熟和（或）去分化的表現(xiàn)。大小改  變細(xì)胞損傷時(shí) zui常見(jiàn)的改變?yōu)榫€(xiàn)粒體腫大。根據(jù)線(xiàn)粒體的受累部  位可分為基質(zhì) 型腫脹和嵴型腫脹二種類(lèi)型，而以前者為常見(jiàn)?；? 質(zhì)型腫脹時(shí)線(xiàn) 粒體變大變圓，基質(zhì)變淺、嵴變短變少甚至消失（  圖－）。在極 度腫脹時(shí)，線(xiàn)粒體可轉(zhuǎn)化為小空泡狀結(jié)構(gòu)。此型腫  脹為細(xì)胞水腫 的部分改變。光學(xué)顯微鏡下所謂的濁腫細(xì)胞中所見(jiàn)  的細(xì)顆粒即腫 大的線(xiàn)粒體。嵴型腫較少見(jiàn)，此時(shí)的腫脹局限于嵴  內(nèi)隙，使扁平 的嵴變成燒瓶狀乃至空泡狀，而基質(zhì)則更顯得致密  。嵴型腫脹一 般為可復(fù)性，但當(dāng)膜的損傷加重時(shí)，可經(jīng)過(guò)混合型  而過(guò)渡為基質(zhì) 型。線(xiàn)粒體為對(duì)損傷極為敏感的細(xì)胞器，其腫脹可  由多種損傷因 子引起，其中zui常見(jiàn)的為缺氧；此外，微生物毒素  、各種毒物、 射線(xiàn)以及滲透壓改變等亦可引起。
For example, when the heart valve mitochondria, peripheral circulatory disorders with intermittent claudication when the skeletal muscle mitochondria showed proliferation. The reduction in the number of mitochondria is seen in the case of mitochondrial disintegration or autolysis in acute cell injury, which lasts for about minutes. Mitochondria are generally not seen (or even increased) due to the gradual proliferation of mitochondria during chronic injury. In addition, the reduction of mitochondria is also a manifestation of immature and/or dedifferentiated cells. The most common change in size when changing cell damage is mitochondrial enlargement. According to the mitochondrial affected area can be divided into two types of matrix-type swelling and sigmoid swelling, while the former is common. When the matrix type swells, the mitochondria become larger and rounder, the matrix becomes lighter, and the enthalpy becomes shorter or less (Fig.-). Mitochondria can be transformed into small vacuoles when they are extremely swollen. This type of swelling is a partial change in cell edema. The fine particles seen in the so-called turbid cells under the light microscope are swollen mitochondria. Sputum swelling is less common. Swelling at this time is limited to the internal iliac crest, making the flat ridge become flask-like or vacuole-like, while the matrix is ??more compact. Sputum swelling is generally reversible, but when the damage to the membrane is aggravated, it can be mixed and transition to a matrix type. Mitochondria are organelles that are extremely sensitive to injury. Swelling can be caused by a variety of injury factors, the most common of which is hypoxia; in addition, microbial toxins, various toxicants, radiation, and changes in osmotic pressure can also be caused.